• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共刺激分子 TNFR2 的表达诱导 CD4+FoxP3-常规 T 细胞抵抗 CD4+FoxP3+调节性 T 细胞的抑制作用。

Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells.

机构信息

Basic Science Program, Science Applications International Corporation-Frederick, Inc., National Cancer Institute, Frederick, MD 21702, USA.

出版信息

J Immunol. 2010 Jul 1;185(1):174-82. doi: 10.4049/jimmunol.0903548. Epub 2010 Jun 4.

DOI:10.4049/jimmunol.0903548
PMID:20525892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6314668/
Abstract

Our previous study showed that TNFR2 is preferentially expressed by CD4(+)FoxP3(+) regulatory T cells (Tregs), and expression of this receptor identified maximally suppressive Tregs. TNFR2 is also expressed by a small fraction of CD4(+)FoxP3(-) conventional T cells (Tconvs) in normal mice, and its expression is upregulated by T cell activation. This raises questions about the role of TNFR2 signaling in the function of Tconv cells. In this study, by using FoxP3/gfp knock-in mice, we showed that TNFR2 signaling did not induce FoxP3(-) CD4 cells to become suppressive. Ki-67, a marker of proliferation, was concomitantly expressed with TNFR2 by CD4 cells, independent of forkhead box P3 expression, in normal mice and Lewis lung carcinoma-bearing mice. TNFR2 is associated with greater suppressive functions when expressed by Tregs and is associated with greater resistance to suppression when expressed by Tconv cells. In mice bearing 4T1 breast tumor or Lewis lung carcinoma, intratumoral Tconv cells expressing elevated levels of TNFR2 acquired the capacity to resist suppression by lymph node-derived Tregs. However, they remained susceptible to inhibition by more suppressive tumor-infiltrating Tregs, which expressed higher levels of TNFR2. Our data indicate that TNFR2 also costimulates Tconv cells. However, intratumoral Tregs expressing more TNFR2 are able to overcome the greater resistance to suppression of intratumoral Tconv cells, resulting in a dominant immunosuppressive tumor environment.

摘要

我们之前的研究表明,TNFR2 优先表达于 CD4+FoxP3+调节性 T 细胞(Tregs),且该受体的表达可鉴定出具有最大抑制功能的 Tregs。在正常小鼠中,TNFR2 也表达于一小部分 CD4+FoxP3-常规 T 细胞(Tconvs),其表达可被 T 细胞激活所上调。这引发了关于 TNFR2 信号在 Tconv 细胞功能中的作用的问题。在这项研究中,我们通过使用 FoxP3/gfp 基因敲入小鼠,表明 TNFR2 信号不会诱导 FoxP3- CD4 细胞成为抑制性细胞。Ki-67 是增殖的标志物,在正常小鼠和 Lewis 肺癌荷瘤小鼠中,与 TNFR2 一起由 CD4 细胞表达,与 FoxP3 表达无关。TNFR2 在 Tregs 中表达时与更强的抑制功能相关,在 Tconv 细胞中表达时与更强的抗抑制能力相关。在携带 4T1 乳腺癌或 Lewis 肺癌的小鼠中,表达高水平 TNFR2 的肿瘤内 Tconv 细胞获得了抵抗淋巴结来源的 Tregs 抑制的能力。然而,它们仍然容易受到表达更高水平 TNFR2 的更多具有抑制功能的肿瘤浸润性 Tregs 的抑制。我们的数据表明,TNFR2 也共刺激 Tconv 细胞。然而,表达更多 TNFR2 的肿瘤内 Tregs 能够克服肿瘤内 Tconv 细胞对抑制的更大抗性,导致占主导地位的免疫抑制肿瘤微环境。

相似文献

1
Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells.共刺激分子 TNFR2 的表达诱导 CD4+FoxP3-常规 T 细胞抵抗 CD4+FoxP3+调节性 T 细胞的抑制作用。
J Immunol. 2010 Jul 1;185(1):174-82. doi: 10.4049/jimmunol.0903548. Epub 2010 Jun 4.
2
Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.前沿:TNFR2的表达定义了小鼠CD4+CD25+FoxP3+调节性T细胞的最大抑制性子集:对肿瘤浸润调节性T细胞的适用性
J Immunol. 2008 May 15;180(10):6467-71. doi: 10.4049/jimmunol.180.10.6467.
3
Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.肿瘤坏死因子(TNF)与2型肿瘤坏死因子受体(TNF receptor type 2)的相互作用可促进小鼠CD4+CD25+调节性T细胞的扩增及功能。
J Immunol. 2007 Jul 1;179(1):154-61. doi: 10.4049/jimmunol.179.1.154.
4
TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment.TNFR2 在炎症环境中对于 CD4+Foxp3+调节性 T 细胞表型的稳定至关重要。
J Immunol. 2013 Feb 1;190(3):1076-84. doi: 10.4049/jimmunol.1202659. Epub 2012 Dec 31.
5
In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.体外生成的Th17细胞在体内支持CD4(+)Foxp3(+)调节性T细胞的扩增和表型稳定性。
Cytokine. 2014 Jan;65(1):56-64. doi: 10.1016/j.cyto.2013.09.008. Epub 2013 Sep 27.
6
Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4 T cells in the draining lymph nodes of breast cancer.调节性 T 细胞在乳腺癌引流淋巴结的 CD4 T 细胞中表达肿瘤坏死因子受体 2 的强度最高。
Mol Immunol. 2021 Sep;137:52-56. doi: 10.1016/j.molimm.2021.06.013. Epub 2021 Jun 29.
7
Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients.外周血中调节性T细胞上TNFR2的表达与肺癌患者的临床病理相关。
Cancer Immunol Immunother. 2015 Nov;64(11):1475-85. doi: 10.1007/s00262-015-1751-z. Epub 2015 Aug 18.
8
Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.TNFR2 和 CD25 的共表达在人外周血中鉴定出更多的功能性 CD4+FOXP3+调节性 T 细胞。
Eur J Immunol. 2010 Apr;40(4):1099-106. doi: 10.1002/eji.200940022.
9
TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40.TNF 通过诱导 TNF 受体超家族成员 TNFR2、4-1BB 和 OX40 来最优地激活调节性 T 细胞。
Eur J Immunol. 2011 Jul;41(7):2010-20. doi: 10.1002/eji.201041205.
10
Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.调节性 T 细胞通过 T 细胞产生的 TNF 和调节性 T 细胞表达的 TNFR2 来控制移植物抗宿主病。
Blood. 2016 Sep 22;128(12):1651-9. doi: 10.1182/blood-2016-02-700849. Epub 2016 Aug 9.

引用本文的文献

1
Longitudinal single cell profiling of epitope specific memory CD4+ T cell responses to recombinant zoster vaccine.针对重组带状疱疹疫苗的表位特异性记忆CD4+ T细胞反应的纵向单细胞分析
Nat Commun. 2025 Mar 8;16(1):2332. doi: 10.1038/s41467-025-57562-7.
2
The immune landscape of the inflamed joint defined by spectral flow cytometry.通过光谱流式细胞术定义炎症关节的免疫景观。
Clin Exp Immunol. 2024 Nov 12;218(3):221-241. doi: 10.1093/cei/uxae071.
3
Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules.

本文引用的文献

1
Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.TNFR2 和 CD25 的共表达在人外周血中鉴定出更多的功能性 CD4+FOXP3+调节性 T 细胞。
Eur J Immunol. 2010 Apr;40(4):1099-106. doi: 10.1002/eji.200940022.
2
Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2).膜型肿瘤坏死因子 (TNF) 通过 TNF 受体-2 (TNFR2) 诱导 p100 加工。
J Biol Chem. 2010 Mar 5;285(10):7394-404. doi: 10.1074/jbc.M109.037341. Epub 2009 Dec 28.
3
Tumour necrosis factor and cancer.
间充质基质/干细胞与免疫检查点相关分子的治疗及免疫调节潜力
Biomark Res. 2024 Mar 21;12(1):35. doi: 10.1186/s40364-024-00580-2.
4
Lymphopenia and high Ki-67 expression in peripheral blood CD4+ and CD8+ T cells associate with progressive sarcoidosis.外周血 CD4+和 CD8+T 细胞中的淋巴细胞减少和 Ki-67 高表达与进行性结节病相关。
BMJ Open Respir Res. 2023 Dec 14;10(1):e001551. doi: 10.1136/bmjresp-2022-001551.
5
Therapeutic potential of TNFR2 agonists: a mechanistic perspective.TNFR2 激动剂的治疗潜力:一种机制观点。
Front Immunol. 2023 Aug 17;14:1209188. doi: 10.3389/fimmu.2023.1209188. eCollection 2023.
6
Editorial: The role of TNF-TNFR2 signal in immunosuppressive cells and its therapeutic implications, volume II.社论:肿瘤坏死因子-肿瘤坏死因子受体2信号在免疫抑制细胞中的作用及其治疗意义,第二卷
Front Immunol. 2023 Aug 1;14:1227003. doi: 10.3389/fimmu.2023.1227003. eCollection 2023.
7
Peripheral blood lymphopenia in sarcoidosis associates with HLA-DRB1 alleles but not with lung immune cells and organ involvement.结节病中的外周血淋巴细胞减少与HLA - DRB1等位基因相关,但与肺免疫细胞及器官受累无关。
Clin Exp Immunol. 2023 Oct 13;213(3):357-362. doi: 10.1093/cei/uxad052.
8
Exosome-Modified Liposomes Targeted Delivery of Thalidomide to Regulate Treg Cells for Antitumor Immunotherapy.外泌体修饰脂质体靶向递送沙利度胺以调节调节性T细胞用于抗肿瘤免疫治疗
Pharmaceutics. 2023 Mar 27;15(4):1074. doi: 10.3390/pharmaceutics15041074.
9
TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments.TNFR2 表达预测免疫检查点抑制剂治疗的反应。
Front Immunol. 2023 Feb 14;14:1097090. doi: 10.3389/fimmu.2023.1097090. eCollection 2023.
10
Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses.联合表达TNFR2的调节性T细胞和白细胞介素-6作为高级别浆液性卵巢癌肿块的卓越诊断生物标志物。
Cancers (Basel). 2023 Jan 21;15(3):667. doi: 10.3390/cancers15030667.
肿瘤坏死因子与癌症
Nat Rev Cancer. 2009 May;9(5):361-71. doi: 10.1038/nrc2628. Epub 2009 Apr 3.
4
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy.环磷酰胺治疗后肿瘤的根除取决于调节性T细胞的同时耗竭:循环表达TNFR2的效应抑制性T细胞在限制有效化疗中的作用。
Cancer Immunol Immunother. 2009 Aug;58(8):1219-28. doi: 10.1007/s00262-008-0628-9. Epub 2008 Dec 4.
5
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells.程序性死亡1配体信号传导调节适应性Foxp3 + CD4 +调节性T细胞的产生。
Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9331-6. doi: 10.1073/pnas.0710441105. Epub 2008 Jul 2.
6
Regulatory T cells and immune tolerance.调节性T细胞与免疫耐受。
Cell. 2008 May 30;133(5):775-87. doi: 10.1016/j.cell.2008.05.009.
7
Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.前沿:TNFR2的表达定义了小鼠CD4+CD25+FoxP3+调节性T细胞的最大抑制性子集:对肿瘤浸润调节性T细胞的适用性
J Immunol. 2008 May 15;180(10):6467-71. doi: 10.4049/jimmunol.180.10.6467.
8
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection.OX40激活可阻止调节性T细胞的抑制作用,并促进肿瘤排斥反应。
J Exp Med. 2008 Apr 14;205(4):825-39. doi: 10.1084/jem.20071341. Epub 2008 Mar 24.
9
Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators.前沿:CD4+CD25+调节性T细胞介导的肿瘤坏死因子受体脱落可抑制炎症介质的诱导。
J Immunol. 2008 Mar 1;180(5):2747-51. doi: 10.4049/jimmunol.180.5.2747.
10
Allograft rejection mediated by memory T cells is resistant to regulation.由记忆T细胞介导的同种异体移植排斥反应对调节具有抗性。
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19954-9. doi: 10.1073/pnas.0704397104. Epub 2007 Nov 27.